High-Dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients

Clinical Trials, High Risk Prostate Cancer, Intermediate Risk Prostate Cancer

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT05838716
Phase: PHASE3
Trial Summary: This phase III trial tests whether high-dose vitamin D works in treating androgen-deprivation therapy (ADT)-induced bone loss in patients with prostate cancer who are undergoing androgen-deprivation t – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): University of Rochester NCORP Research Base
Acronym:

Pin It on Pinterest